MediPharm Labs has exported medical cannabis to Barbados for the first time together with its partner Avicanna. The company has manufactured and delivered products for the medical community and patients in the Caribbean through Bryden Stokes, an established health and pharmaceutical product distributor in the region.
"We will continue to deliver to international jurisdictions with medical cannabis programs in place. This execution is a proof of concept for future pharmaceutical customers who choose us to manufacture novel and generic drugs with marketing authorization for physician prescriptions in regions like the United States and the European Union," said Bryan Howcroft, CEO, MediPharm Labs. “As countries around the world continue to adopt medical cannabis programs, MediPharm Labs is best positioned to serve these markets as the only North American producer with a Drug Establishment License (GMP) for the extraction of natural cannabinoids.”
For more information:
151 John Street, Barrie
+1 705 719 7425